U2Bio Co., Ltd. (KOSDAQ:221800)
26,850
0.00 (0.00%)
At close: Feb 26, 2026
636.63% (1Y)
| Market Cap | 427.79B |
| Revenue (ttm) | 25.59B |
| Net Income (ttm) | -2.99B |
| Shares Out | 15.93M |
| EPS (ttm) | -265.81 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.37%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 7,770,604 |
| Average Volume | 3,456,153 |
| Open | 25,700 |
| Previous Close | n/a |
| Day's Range | 25,200 - 32,800 |
| 52-Week Range | 2,850 - 32,800 |
| Beta | -0.12 |
| RSI | 70.69 |
| Earnings Date | n/a |